Literature DB >> 23231670

Effects of combined radiation and burn injury on the renin-angiotensin system.

Sachin S Jadhav1, Natasha Sharma, Christopher J Meeks, Nicholas M Mordwinkin, Theresa B Espinoza, Norma R Roda, Gere S DiZerega, Colin K Hill, Stan G Louie, Kathleen E Rodgers.   

Abstract

The renin-angiotensin system (RAS) plays an important role in wound repair; however, little is known pertaining to RAS expression in response to thermal injury and the combination of radiation plus burn injury (CRBI). The purpose of this study was to test the hypothesis that thermal injury modifies expression of RAS components and CRBI delayed this up-regulation of RAS. Skin from uninjured mice was compared with mice receiving local thermal injury or CRBI (injury site). Skin was analyzed for gene and protein expression of RAS components. There was an initial increase in the expression of various components of RAS following thermal injury. However, in the higher CRBI group there is an initial decrease in AT(1b) (vasoconstriction, pro-proliferative), AT(2) (vasodilation, differentiation), and Mas (vasodilation, anti-inflammatory) gene expression. This corresponded with a delay and decrease in AT(1) , AT(2) , and MAS protein expression in fibroblasts and keratinocytes. The reduction in RAS receptor positive fibroblasts and keratinocytes correlated with a reduction in collagen deposition and keratinocyte infiltration into the wounded area resulting in a delay of reepithelialization following CRBI. These data support the hypothesis that delayed wound healing observed in subjects following radiation exposure may be in part due to decreased expression of RAS.
© 2012 by the Wound Healing Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23231670      PMCID: PMC3540151          DOI: 10.1111/j.1524-475X.2012.00867.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  50 in total

1.  Immunohistochemical analysis of radiation-induced non-healing dermal wounds of the head and neck.

Authors:  Frank Riedel; Katrin Philipp; Haneen Sadick; Ullrich Goessler; Karl Hörmann; Thomas Verse
Journal:  In Vivo       Date:  2005 Mar-Apr       Impact factor: 2.155

2.  Effects of angiotensin II receptor signaling during skin wound healing.

Authors:  Hikaru Takeda; Yohtaro Katagata; Yutaka Hozumi; Shigeo Kondo
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

3.  G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor.

Authors:  Evi Kostenis; Graeme Milligan; Arthur Christopoulos; Carlos F Sanchez-Ferrer; Silvia Heringer-Walther; Patrick M Sexton; Florian Gembardt; Elaine Kellett; Lene Martini; Patrick Vanderheyden; Heinz-Peter Schultheiss; Thomas Walther
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

4.  Acceleration of dermal tissue repair by angiotensin II.

Authors:  K Rodgers; M Abiko; W Girgis; K St Amand; J Campeau; G diZerega
Journal:  Wound Repair Regen       Date:  1997 Apr-Jun       Impact factor: 3.617

5.  Effect of angiotensin II on hematopoietic progenitor cell proliferation.

Authors:  K E Rodgers; S Xiong; R Steer; G S diZerega
Journal:  Stem Cells       Date:  2000       Impact factor: 6.277

6.  Alterations of angiotensin II Receptor levels in sutured wounds in rat skin.

Authors:  M Abiko; K E Rodgers; J D Campeau; R M Nakamura; G S Dizerega
Journal:  J Invest Surg       Date:  1996 Nov-Dec       Impact factor: 2.533

7.  Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis.

Authors:  Kátia Daniela da Silveira; Fernanda Matos Coelho; Angélica Thomáz Vieira; Daniela Sachs; Lívia Corrêa Barroso; Vivian Vasconcelos Costa; Thales Lages Bicalho Bretas; Michael Bader; Lirlândia Pires de Sousa; Tarcília Aparecida da Silva; Robson Augusto Souza dos Santos; Ana Cristina Simões e Silva; Mauro Martins Teixeira
Journal:  J Immunol       Date:  2010-10-08       Impact factor: 5.422

8.  Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors.

Authors:  P E Ray; L A Bruggeman; S Horikoshi; G Aguilera; P E Klotman
Journal:  Kidney Int       Date:  1994-01       Impact factor: 10.612

9.  Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.

Authors:  A J Naftilan; R E Pratt; V J Dzau
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

10.  Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice.

Authors:  Maya Kurosaka; Tatsunori Suzuki; Kanako Hosono; Yuji Kamata; Akiyoshi Fukamizu; Hidero Kitasato; Yoshikuni Fujita; Masataka Majima
Journal:  Biomed Pharmacother       Date:  2009-02-14       Impact factor: 6.529

View more
  7 in total

1.  Angiotensin II stimulates canonical TGF-β signaling pathway through angiotensin type 1 receptor to induce granulation tissue contraction.

Authors:  Tosan Ehanire; Licheng Ren; Jennifer Bond; Manuel Medina; George Li; Latif Bashirov; Lei Chen; George Kokosis; Mohamed Ibrahim; Angelica Selim; Gerard C Blobe; Howard Levinson
Journal:  J Mol Med (Berl)       Date:  2014-10-28       Impact factor: 4.599

Review 2.  NorLeu3-Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers.

Authors:  Kathleen E Rodgers; Laura L Bolton; Shelagh Verco; Gere S diZerega
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-06-01       Impact factor: 4.730

Review 3.  Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7).

Authors:  Kathleen Rodgers; Shelagh Verco; Laura Bolton; Gere Dizerega
Journal:  Expert Opin Investig Drugs       Date:  2011-10-06       Impact factor: 6.206

Review 4.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

5.  MicroRNA expression profiling altered by variant dosage of radiation exposure.

Authors:  Kuei-Fang Lee; Yi-Cheng Chen; Paul Wei-Che Hsu; Ingrid Y Liu; Lawrence Shih-Hsin Wu
Journal:  Biomed Res Int       Date:  2014-09-16       Impact factor: 3.411

6.  Improving the Innate Immune Response in Diabetes by Modifying the Renin Angiotensin System.

Authors:  Maira Soto; Kevin J Gaffney; Kathleen E Rodgers
Journal:  Front Immunol       Date:  2019-12-10       Impact factor: 7.561

Review 7.  Contribution of the Local RAS to Hematopoietic Function: A Novel Therapeutic Target.

Authors:  Kathleen E Rodgers; Gere S Dizerega
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-23       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.